Literature DB >> 2553583

Unequal expression of complement C4A and C4B genes in rheumatoid synovial cells, human monocytoid and hepatoma-derived cell lines.

A Falus1, J Kramer, E Walcz, Z Varga, J Setalo, K Jobst, T Lakatos, K Merétey.   

Abstract

C4A and C4B are closely related homologous complement proteins encoded in the class III region of major histocompatibility complex (MHC). The regulation of their expression is under genetic and hormonal control. In this study we investigated the synovial fluid plasma ratio of C4A and C4B of rheumatoid (RA) and osteoarthritis (OA) patients, and a predominance of the C4B gene expression by the synovial macrophages of RA patients was demonstrated. To clarify the tissue specificity of the expression of C4A and C4B genes, human monocytoid cell line U937 and hepatoma-derived HepG2 cells were studied. The gene expression of C4A and C4B were markedly different in these cells since a relative predominance of C4B mRNA in U937 cells and excess of that of C4A in HepG2 cells were detected. Recombinant interferon-gamma (IFN-gamma) up-regulated the expression of C4A gene in both cells, but had apparently no effect on the C4B gene. Our results demonstrate dissimilar expression patterns for the two human C4 genes, suggesting different tissue specific regulation of human C4A and C4B.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553583      PMCID: PMC1385517     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues.

Authors:  S Ruddy; H R Colten
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

2.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

Review 3.  Biosynthesis of the MHC-linked complement proteins (C2, C4 and factor B) by mononuclear phagocytes.

Authors:  H R Colten
Journal:  Mol Immunol       Date:  1982-10       Impact factor: 4.407

4.  A haemolytically non-active C4 gene product.

Authors:  P Teisberg; B Olaisen; R Nordhagen; E Thorsby; T Geddedahl
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

5.  Cloning of a human complement component C4 gene.

Authors:  M C Carroll; R R Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  The structural basis of the multiple forms of human complement component C4.

Authors:  K T Belt; M C Carroll; R R Porter
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

7.  A molecular basis for the two locus model of human complement component C4.

Authors:  M H Roos; E Mollenhauer; P Démant; C Rittner
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

8.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

Review 9.  Two isotypes of human C4, C4A and C4B have different structure and function.

Authors:  J A Schifferli; J P Paccaud
Journal:  Complement Inflamm       Date:  1989

10.  A comparison of the properties of two classes, C4A and C4B, of the human complement component C4.

Authors:  S K Law; A W Dodds; R R Porter
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  2 in total

1.  Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes.

Authors:  M L Lokki; S A Koskimies
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Early diagnosis of colorectal cancer via plasma proteomic analysis of CRC and advanced adenomatous polyp.

Authors:  Setareh Fayazfar; Hakimeh Zali; Afsaneh Arefi Oskouie; Hamid Asadzadeh Aghdaei; Mostafa Rezaei Tavirani; Ehsan Nazemalhosseini Mojarad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.